These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 20140432

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Enhancement of umbilical cord blood cell hematopoiesis by maitake beta-glucan is mediated by granulocyte colony-stimulating factor production.
    Lin H, Cheung SW, Nesin M, Cassileth BR, Cunningham-Rundles S.
    Clin Vaccine Immunol; 2007 Jan; 14(1):21-7. PubMed ID: 17093103
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
    Tanikawa S, Nakao I, Tsuneoka K, Nara N.
    Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
    [Abstract] [Full Text] [Related]

  • 5. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
    Laughlin MJ, Kirkpatrick G, Sabiston N, Peters W, Kurtzberg J.
    Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
    [Abstract] [Full Text] [Related]

  • 6. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
    Peters WP, Rosner G, Ross M, Vredenburgh J, Meisenberg B, Gilbert C, Kurtzberg J.
    Blood; 1993 Apr 01; 81(7):1709-19. PubMed ID: 7681699
    [Abstract] [Full Text] [Related]

  • 7. Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study.
    Wesa KM, Cunningham-Rundles S, Klimek VM, Vertosick E, Coleton MI, Yeung KS, Lin H, Nimer S, Cassileth BR.
    Cancer Immunol Immunother; 2015 Feb 01; 64(2):237-47. PubMed ID: 25351719
    [Abstract] [Full Text] [Related]

  • 8. The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys.
    Neelis KJ, Hartong SC, Egeland T, Thomas GR, Eaton DL, Wagemaker G.
    Blood; 1997 Oct 01; 90(7):2565-73. PubMed ID: 9326222
    [Abstract] [Full Text] [Related]

  • 9. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice.
    Brasel K, McKenna HJ, Charrier K, Morrissey PJ, Williams DE, Lyman SD.
    Blood; 1997 Nov 01; 90(9):3781-8. PubMed ID: 9345066
    [Abstract] [Full Text] [Related]

  • 10. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro.
    Lin H, She YH, Cassileth BR, Sirotnak F, Cunningham Rundles S.
    Int Immunopharmacol; 2004 Jan 01; 4(1):91-9. PubMed ID: 14975363
    [Abstract] [Full Text] [Related]

  • 11. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 01; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow.
    Benboubker L, Cartron G, Roingeard F, Delain M, Degenne M, Linassier C, Hérault O, Truglio D, Bout M, Petit A, Brémond JL, Desbois I, Colombat P, Binet C, Domenech J.
    Exp Hematol; 2003 Jan 01; 31(1):89-97. PubMed ID: 12543111
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF.
    Ballestrero A, Ferrando F, Garuti A, Basta P, Gonella R, Stura P, Mela GS, Sessarego M, Gobbi M, Patrone F.
    J Clin Oncol; 1999 Apr 01; 17(4):1296. PubMed ID: 10561192
    [Abstract] [Full Text] [Related]

  • 20. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM, Gulati SC, Strife A, Lambek C, Perez A, Clarkson BD.
    Leukemia; 1991 May 01; 5(5):386-91. PubMed ID: 1709711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.